Reusable Pen Injector Global Market Report 2026

A reusable pen injector is a durable, manually operated medication delivery device developed for repeated administration of accurate doses of injectable drugs through replaceable cartridges and removable needles, providing controlled dosing, improved usability, and greater convenience for long-term treatment management while reducing material consumption compared to disposable injection systems. These devices are extensively used in the treatment of chronic conditions and self-administered therapies across healthcare environments, supporting patient compliance, dosing precision, portability, and effective medication delivery in both clinical and home-care settings.

The primary product categories of reusable pen injectors include manual reusable pen injectors and smart reusable pen injectors. Manual reusable pen injectors are medication delivery devices intended for repeated use, enabling patients to administer accurate doses through replaceable cartridges. These products are manufactured from materials such as plastic, metal, glass, and composite material combinations. Their applications include diabetes management, hormonal therapies, anaphylaxis treatment, chronic disease management, and vaccination, serving end users such as hospitals and clinics, home care environments, pharmaceutical companies, research institutions, and academic and training organizations.

Tariffs are influencing the reusable pen injector market by increasing the cost of imported precision components, cartridges, and electronic modules used in advanced injector systems, thereby raising overall manufacturing costs and impacting device affordability across healthcare markets. This is slowing supply chains for pharmaceutical firms and medical device manufacturers, particularly in import-dependent regions such as Asia-Pacific and Latin America where reliance on foreign components is significant. Hardware-intensive segments such as smart reusable pen injectors and metal-based delivery mechanisms are most affected due to global sourcing dependencies. However, tariffs are also promoting localized manufacturing, strengthening regional supply chains, and driving investment in domestic medical device ecosystems, which is improving long-term market resilience.

The reusable pen injector market size has grown strongly in recent years. It will grow from $4.46 billion in 2025 to $4.83 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to rise in diabetes and chronic disease prevalence, introduction of insulin pen injector systems, expansion of self administration drug delivery practices, improvement in healthcare infrastructure and access, increasing focus on dosing accuracy and patient adherence.

The reusable pen injector market size is expected to see strong growth in the next few years. It will grow to $6.73 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to growth of smart connected injector ecosystems, expansion of home based healthcare delivery models, integration of digital dose tracking and analytics, rising adoption of biologics and biosimilar injectable therapies, increasing demand for sustainable and reusable medical devices. Major trends in the forecast period include smart reusable pen injectors with dose tracking integration, increasing adoption of home-based self-administration for chronic disease management, growing demand for cartridge-based modular drug delivery systems, rising focus on ergonomic and patient-centric injector designs, expansion of biologics and biosimilars requiring high-precision dosing devices.

The growing prevalence of diabetes is anticipated to drive the expansion of the reusable pen injector market in the coming years. Diabetes is a long-term metabolic disorder characterized by elevated blood glucose levels resulting from inadequate insulin production or ineffective utilization of insulin by the body. Its prevalence is rising due to increasing obesity rates, sedentary lifestyles, and aging populations, all of which contribute to impaired glucose metabolism and a higher global incidence of the disease. Reusable pen injectors assist in diabetes management by allowing precise, convenient, and repeatable self-administration of insulin and other injectable therapies, thereby enhancing long-term treatment adherence and improving glycemic control. For instance, in August 2023, according to the International Diabetes Federation (IDF), a Belgium-based nonprofit organization, an estimated 11.1% of adults aged 20-79 years, equivalent to 1 in 9 individuals, were living with diabetes in 2025, with more than 40% remaining undiagnosed, while projections suggest that by 2050 nearly 1 in 8 adults, or around 853 million people, will be affected, representing a 46% increase. Therefore, the growing prevalence of diabetes is driving the growth of the reusable pen injector market.

Key companies operating in the reusable pen injector market are concentrating on the development of innovative products such as multi-dose injection pens to enhance dosing flexibility, patient adherence, and cost-efficient chronic disease management. A multi-dose injection pen is a reusable drug delivery device engineered to deliver multiple adjustable doses of injectable medication from replaceable or prefilled cartridges. For example, in March 2026, Zydus Lifesciences Limited, an India-based global life sciences company, introduced Semaglutide Injection, a reusable multi-dose pen device. The device allows patients and healthcare professionals to administer different dose strengths using a single reusable pen, thereby reducing reliance on multiple disposable injection systems during dose escalation therapy. This innovation improves treatment accessibility and convenience while supporting better adherence and reducing long-term therapy costs for diabetes and obesity management.

In May 2026, Embecta, a US-based supplier of insulin delivery devices, pen needles, syringes, and diabetes care solutions, acquired Owen Mumford Holdings for $201 million. Through this acquisition, Embecta aimed to extend its reach beyond diabetes care by enhancing its injectable drug delivery capabilities and expanding its presence in autoimmune disease, biologics, and anaphylaxis treatment markets through Owen Mumford's auto-injector platform and manufacturing expertise. Owen Mumford Holdings is a UK-based provider of auto-injectors, reusable insulin pen injectors, lancets, syringes, pen needles, and additional self-injection and medical device solutions.

Major companies operating in the reusable pen injector market are Novo Nordisk AS; Eli Lilly and Company; Sanofi SA; SHL Medical AG; Ypsomed AG; Stevanato Group S.p.A; Becton Dickinson and Company; Gerresheimer AG; Medtronic plc; Nemera; Owen Mumford Ltd.; medmix AG; Embecta Corp.; AptarGroup Inc.; West Pharmaceutical Services Inc.; Biocon Limited; Duoject Medical Systems Inc.; Bespak; Lepu Medical Technology Beijing Co. Ltd.; Wockhardt Limited; GenSci Pharmaceutical Co. Ltd.; Jiangsu Delfu Medical Device Co. Ltd.; Credence MedSystems; Phillips-Medisize.

North America was the largest region in the reusable pen injector market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the reusable pen injector market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the reusable pen injector market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The reusable pen injector market consists of sales of cartridge-based drug delivery pens, adjustable-dose injection devices, and related accessories. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The reusable pen injector market research report is one of a series of new reports from The Business Research Company that provides reusable pen injector market statistics, including reusable pen injector industry global market size, regional shares, competitors with a reusable pen injector market share, detailed reusable pen injector market segments, market trends and opportunities, and any further data you may need to thrive in the reusable pen injector industry. This reusable pen injector market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Reusable Pen Injector Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses reusable pen injector market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for reusable pen injector ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The reusable pen injector market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Manual Reusable Pen Injectors; Smart Reusable Pen Injectors
• 2) By Material: Plastic; Metal; Glass; Combination Materials
• 3) By Application: Diabetes Management; Hormonal Therapies; Anaphylaxis Treatment; Chronic Diseases; Vaccination
• 4) By End User: Hospitals And Clinics; Home Care Settings; Pharmaceutical Companies; Research Institutions; Academic And Training Institutions
• Subsegments:
• 1) By Manual Reusable Pen Injectors: Spring Driven Manual Pen Injectors; Dial Dose Manual Pen Injectors; Push Button Manual Pen Injectors; Twist Dose Manual Pen Injectors
• 2) By Smart Reusable Pen Injectors: Bluetooth Enabled Smart Pen Injectors; Mobile Application Connected Smart Pen Injectors; Dose Tracking Smart Pen Injectors; Data Logging Smart Pen Injectors
• Companies Mentioned: Novo Nordisk AS; Eli Lilly and Company; Sanofi SA; SHL Medical AG; Ypsomed AG; Stevanato Group S.p.A; Becton Dickinson and Company; Gerresheimer AG; Medtronic plc; Nemera; Owen Mumford Ltd.; medmix AG; Embecta Corp.; AptarGroup Inc.; West Pharmaceutical Services Inc.; Biocon Limited; Duoject Medical Systems Inc.; Bespak; Lepu Medical Technology Beijing Co. Ltd.; Wockhardt Limited; GenSci Pharmaceutical Co. Ltd.; Jiangsu Delfu Medical Device Co. Ltd.; Credence MedSystems; Phillips-Medisize.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.